Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...
Q4 sales performance exceeded guidance, driven by better-than-expected sales in Medical Products, Kidney Care, Pharmaceuticals. Baxter reported improved profitability in fourth quarter. Brand New ...
What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 4.5% in the afternoon session after Barclays ...